Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial-Reference-Cited by-同舟云学术

Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial

Published:2010-06 Issue:6 Volume:159 Page:988-997
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Simes R. John,O'Connell Rachel L.,Aylward Philip E.,Varshavsky Sergei,Diaz Rafael,Wilcox Robert G.,Armstrong Paul W.,Granger Christopher B.,French John K.,Van de Werf Frans,Marschner Ian C.,Califf Rob,White Harvey D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference43 articles.

1. Mackay J, Mensah G, editors. Atlas of heart disease and stroke. Geneva: World Health Organization; 2004. Available at: http://www.who.int/cardiovascular_diseases/resources/atlas/en/index.html. Last accessed June 2008.

2. Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE);Fox;Eur Heart J,2002

3. [editorial] Has the mortality rate from acute myocardial infarction fallen substantially in recent years?;Wong;Eur Heart J,2002

4. What is the real hospital mortality from acute myocardial infarction? Epidemiological vs clinical view;Kuch;Eur Heart J,2002

5. Cardiovascular disease in the developing world and its cost-effective management;Gaziano;Circulation,2005

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotective Effect of Opioids, Derivatives of Amide N-Methyl-2-(Pirrolidin-1-yl)Cyclohexyl-1-Amine, under Conditions of Ischemia/Reperfusion of the Heart;Bulletin of Experimental Biology and Medicine;2021-04

2. Challenges of international oncology trial collaboration—a call to action;British Journal of Cancer;2019-08-05

3. Heart failure with preserved ejection fraction: A systemic disease linked to multiple comorbidities, targeting new therapeutic options;Archives of Cardiovascular Diseases;2018-12

4. In the transition from fibrinolysis to primary PCI, the HERO trials help refine STEMI ECG interpretation and Q wave analysis potentially alters future management;European Heart Journal: Acute Cardiovascular Care;2018-08-17

5. The effect of allogeneic cardiac stem cells in left ventricular geometry and function in a rat model of myocardial infarction;Cardiovascular Therapeutics;2017-12-09